Press "Enter" to skip to content

New patent for Tersera drug XERMELO

0
Copyright © DrugPatentWatch. Originally published at New patent for Tersera drug XERMELO

Annual Drug Patent Expirations for XERMELO
Annual Drug Patent Expirations for XERMELO

Xermelo is a drug marketed by Tersera and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.

This drug has sixty-one patent family members in twenty-nine countries.

The generic ingredient in XERMELO is telotristat etiprate. Two suppliers are listed for this compound. Additional details are available on the telotristat etiprate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Tersera drug XERMELO
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions